Indiamed Globals

Product Description:
Anaridex (Anastrozole) is a potent aromatase inhibitor used to treat hormone receptor-positive breast cancer in postmenopausal women. By lowering estrogen levels, Anastrozole helps slow down or stop the growth of cancer cells that rely on estrogen to grow.

Indications:

• Hormone receptor-positive breast cancer in postmenopausal women
• Adjuvant treatment of early breast cancer
• Treatment of advanced breast cancer

Dosage and Administration:
Typically, Anaridex is taken once daily, with or without food, as prescribed by a healthcare provider. The standard dose is 1 mg per day.

Common side effects include:

• Hot flashes
• Fatigue
• Joint pain
• Osteoporosis

Product Description:
Tagrisso 80mg Tablet contains Osimertinib, a targeted cancer therapy used in the treatment of non-small cell lung cancer (NSCLC) that has specific mutations in the epidermal growth factor receptor (EGFR). Osimertinib is an EGFR tyrosine kinase inhibitor (TKI) that works by blocking the activity of the mutated EGFR, which drives the growth and spread of cancer cells. It is particularly effective against NSCLC that has developed resistance to other EGFR inhibitors.

Common indications for Tagrisso 80mg Tablet include:

• Cancer Treatment: Used in the management of non-small cell lung cancer (NSCLC) with specific EGFR mutations.

Dosage and Administration:

• For Adults: The typical dose is one 80 mg tablet taken orally once daily. The exact dosage and duration of treatment are determined by the oncologist based on the patient's condition and response to therapy.
• Administration: Tagrisso should be taken with or without food, and at the same time each day.

Common side effects of Tagrisso 80mg Tablet may include:

• Diarrhea
• Rash
• Dry skin
• Stomatitis (inflammation of the mouth)
• Nail changes

Serious side effects can include interstitial lung disease, QT prolongation (a type of heart rhythm problem), and low blood cell counts. Regular monitoring of lung function, heart function, and blood tests is essential during treatment.

Packaging:
Tagrisso 80mg Tablet is typically packaged in a box containing 30 tablets, with each tablet individually sealed to ensure proper dosage and patient safety.

Tagrisso 80mg Tablet is a vital medication in the treatment of non-small cell lung cancer (NSCLC) with specific EGFR mutations. It offers a targeted approach that can significantly improve outcomes for patients with this type of cancer. However, due to its potential for serious side effects, it should be used under the guidance and supervision of an experienced oncologist. Regular monitoring of patient health and response to therapy is crucial during treatment with Osimertinib.

• Abiraterone acetate belongs to a class drugs known as antiandrogens. It stops the body from making testosterone which can slow the growth of prostate cancer.

Product Description:
Bracanat 150mg Tablet contains Olaparib, a poly (ADP-ribose) polymerase (PARP) inhibitor used in the treatment of various cancers, particularly those associated with BRCA gene mutations. Olaparib works by blocking the PARP enzyme, which helps repair damaged DNA in cells. By inhibiting this enzyme, Olaparib prevents cancer cells from repairing themselves, leading to their death.

Common indications for Bracanat 150mg Tablet include:

• Ovarian Cancer: Used in the maintenance treatment of adult patients with advanced ovarian cancer who have responded to first-line platinum-based chemotherapy.
• Breast Cancer: Used in the treatment of HER2-negative breast cancer with BRCA1/2 mutations.
• Pancreatic Cancer: Used in the maintenance treatment of BRCA-mutated metastatic pancreatic cancer.
• Prostate Cancer: Used in the treatment of metastatic castration-resistant prostate cancer with BRCA1/2 mutations.

Dosage and Administration:

• For Adults: The usual recommended dose is 300 mg (two 150 mg tablets) taken orally twice daily, for a total daily dose of 600 mg.
• Administration: The tablet should be swallowed whole with water, taken at approximately the same times each day, with or without food. It should not be crushed, chewed, or split.

Common side effects of Bracanat 150mg Tablet may include:

• Nausea
• Fatigue
• Anemia
• Vomiting
• Diarrhea
• Loss of appetite

Regular blood tests and monitoring are essential during treatment to manage potential side effects and adjust the dosage as needed.

Packaging:
Bracanat 150mg Tablet is typically packaged in blister packs containing 14 tablets, designed for a one-week course of treatment when taken as prescribed.

Bracanat 150mg Tablet is a significant advancement in cancer treatment, offering targeted therapy for patients with specific genetic mutations. It plays a crucial role in extending survival and improving the quality of life for patients with certain types of advanced cancers, particularly those associated with BRCA mutations. Regular monitoring and adherence to the prescribed regimen are vital to achieving the best possible outcomes.

Product Description: Alfoo 10mg contains Alfuzosin 10mg, an alpha-blocker used to treat symptoms of benign prostatic hyperplasia (BPH), a condition in which the prostate gland is enlarged in men, causing difficulty in urination. Alfuzosin works by relaxing the muscles in the prostate and the bladder neck, making it easier to urinate and improving urine flow.

This medication is typically prescribed for men who have BPH, which can cause symptoms like frequent urination, a weak stream, or an inability to empty the bladder completely. Alfuzosin helps relieve these symptoms but does not shrink the prostate or prevent its further enlargement.

Common side effects of Alfoo 10mg include dizziness, headache, fatigue, or fainting, especially when standing up quickly (orthostatic hypotension). It is advised to rise slowly from a sitting or lying position to minimize the risk of dizziness.

Patients are recommended to take this medication as prescribed, usually once daily after a meal. Alfoo 10mg should not be taken on an empty stomach. It is also important to follow up with the doctor regularly to monitor the effectiveness of the treatment and adjust the dosage if necessary.

This medication may interact with other drugs, so it is important to inform the doctor of all other medications being taken. Additionally, Alfoo should be used with caution in individuals with a history of heart problems, and it is not suitable for use in women or children.

• Take this medicine by mouth with a glass of water. Follow the directions on the prescription label. Do not cut, crush or chew this medicine. Take this medicine on an empty stomach, at least 1 hour before or 2 hours after meals. Do not take with food. Take your medicine at regular intervals. Do not take it more often than directed. Do not stop taking except on your doctor's advice. Talk to your pediatrician regarding the use of this medicine in children. Special care may be needed. Overdosage: If you think you have taken too much of this medicine contact a poison control center or emergency room at once.

Product Description:
Tykerb 250 mg Tablet contains Lapatinib, a tyrosine kinase inhibitor used in the treatment of HER2-positive breast cancer. Lapatinib targets specific receptors involved in cancer cell growth, particularly the human epidermal growth factor receptor 2 (HER2) and epidermal growth factor receptor (EGFR). By inhibiting these receptors, Tykerb helps to slow down or stop the growth of cancer cells.

Common indications for Tykerb Tablet include:

• HER2-Positive Breast Cancer: Tykerb is used in combination with other medications, such as capecitabine or letrozole, to treat HER2-positive metastatic breast cancer that has not responded to previous therapies.

Dosage and Administration: The usual dosage of Tykerb is determined by the healthcare provider based on the patient’s specific condition and response to treatment. It is important to follow the prescribed dosage and administration schedule as directed.

Common side effects of Tykerb may include:

• Diarrhea
• Nausea
• Vomiting
• Fatigue
• Rash
• Liver enzyme abnormalities

More serious side effects can include potential cardiac issues, severe liver problems, and severe allergic reactions. Regular monitoring and follow-ups with the healthcare provider are essential to manage these potential risks and adjust the treatment as needed.

Packaging: Tykerb 250 mg is typically available in blister packs containing 30 tablets. This packaging helps ensure the medication's stability and allows for convenient dosing.

Tykerb is manufactured by GlaxoSmithKline (GSK), a leading pharmaceutical company known for its high-quality products. It offers a targeted therapy option for managing HER2-positive breast cancer, providing a critical tool for patients with this type of cancer. Regular consultations with healthcare professionals are important for monitoring the effectiveness of the therapy and managing any potential side effects.

Product Description: Silofast 8mg Capsules contain Silodosin 8mg, a selective alpha-1 adrenergic receptor antagonist that is primarily used to treat symptoms of benign prostatic hyperplasia (BPH), a non-cancerous enlargement of the prostate gland in men. By relaxing the muscles in the prostate and bladder neck, Silodosin helps relieve symptoms such as difficulty in urination, a weak urine stream, and frequent or urgent urination, allowing smoother urine flow.

Silofast is highly effective in improving urinary symptoms and quality of life for men with BPH. It specifically targets the alpha-1A receptors in the prostate, minimizing the effect on blood pressure compared to other alpha-blockers. This makes it suitable for older patients or those with comorbidities.

Common side effects include dizziness, retrograde ejaculation (where semen enters the bladder instead of exiting through the penis), and a runny or stuffy nose. It is advised to take the capsule with food to reduce the risk of side effects, and patients should avoid operating heavy machinery or driving until they know how the medication affects them.

Silofast 8mg should be used under medical supervision, and patients are encouraged to consult their healthcare provider if they experience any severe side effects or if their symptoms do not improve. Regular follow-ups may be necessary to monitor the progression of BPH and the effectiveness of the treatment.

• Kidney cancer

Product Description:
Tretinoin CA Atra 10mg Softgel Capsules contain Tretinoin, a derivative of vitamin A, also known as all-trans retinoic acid (ATRA). This medication is used primarily in the treatment of acute promyelocytic leukemia (APL), a subtype of acute myeloid leukemia. Tretinoin works by promoting the differentiation of immature blood cells into normal cells, helping to restore normal blood cell production.

In addition to its use in treating APL, Tretinoin is also prescribed for the management of severe acne that has not responded to other treatments. It works by promoting skin cell turnover, reducing the formation of acne and unclogging pores.

Tretinoin softgel capsules are typically part of a combination therapy, particularly in APL treatment, and they are often used alongside other chemotherapy agents. Regular monitoring by a healthcare provider is essential during treatment, and it may take some time to observe the full therapeutic effects